Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.96 [0.94-0.98],8.60974723400986e-05,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.18 [1.09-1.29],0.000128570561920978,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.97 [0.95-0.99],0.000211957614583607,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.96 [0.94-0.98],0.00023256050493268,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.1 [1.04-1.16],0.000786212581449586,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.04 [1.01-1.07],0.00231191848368376,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,21,1.05 [1.02-1.08],0.00315292167043474,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.95 [0.92-0.99],0.00468091902536155,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PALM,Paralemmin-1,Inverse variance weighted,6,0.86 [0.78-0.96],0.00657623335127493,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.11 [1.02-1.2],0.0118113341922236,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.95 [0.92-0.99],0.0121350203731041,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS3,Galectin-3,Inverse variance weighted,25,1.05 [1.01-1.08],0.0140530704872249,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.96 [0.93-0.99],0.0147467855403474,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.95 [0.92-0.99],0.0158221430374084,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.95 [0.91-0.99],0.0158443333875997,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.94 [0.89-0.99],0.0169040023514976,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PVR,Poliovirus receptor,Inverse variance weighted,27,1.03 [1-1.05],0.0173543026159007,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.91 [0.84-0.99],0.0195888722256367,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.1 [1.01-1.2],0.0223450688960518,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.95 [0.92-0.99],0.0225874358094742,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.09 [1.01-1.19],0.0283181307393388,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.08 [1.01-1.15],0.0286369160059707,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH2,Cadherin-2,Inverse variance weighted,3,0.82 [0.68-0.98],0.029956743357647,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RGMB,RGM domain family member B,Inverse variance weighted,9,0.92 [0.86-0.99],0.0336240925264182,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.05 [1-1.1],0.0336315414533515,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,0.98 [0.96-1],0.035285516579616,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C7,Complement component C7,Inverse variance weighted,38,1.02 [1-1.05],0.0354378404083066,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS4,Galectin-4,Inverse variance weighted,4,1.12 [1.01-1.24],0.0376592203530844,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSS,Cathepsin S,Inverse variance weighted,23,0.97 [0.93-1],0.0382577337950174,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.87 [0.77-0.99],0.0399252290915712,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.03 [1-1.05],0.0399353747600535,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.95 [0.9-1],0.0408474392620718,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.94 [0.89-1],0.0431526725427278,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC3B,Tetranectin,Inverse variance weighted,7,0.93 [0.87-1],0.0434292789791956,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.12 [1-1.25],0.043573379300152,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.05 [1-1.11],0.0460486138784382,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.62 [0.38-0.99],0.0475445290572264,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.06 [1-1.12],0.0496327208611233,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.83 [0.69-1],0.0505424021468689,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.98 [0.96-1],0.0521012464731135,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.95 [0.91-1],0.0536376535976852,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.35 [0.99-1.84],0.0540824317915,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.04 [1-1.08],0.0572894598504455,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.07 [1-1.15],0.0604984217106249,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.91 [0.82-1],0.0608284135972019,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.93 [0.86-1],0.061857193127498,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.06 [1-1.13],0.0622466955348067,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,1.05 [1-1.1],0.06296039819381,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HJV,Hemojuvelin,Wald ratio,1,0.92 [0.84-1],0.0635808185285038,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NRP2,Neuropilin-2,Inverse variance weighted,11,0.94 [0.88-1.01],0.0743736851543017,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LMNB2,Lamin-B2,Wald ratio,1,1.44 [0.96-2.18],0.0808889424416988,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.85 [0.71-1.02],0.0843870453764223,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP2,Retinol-binding protein 2,Wald ratio,1,1.27 [0.96-1.67],0.0903274282873606,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.04 [0.99-1.09],0.0913062516731141,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OCLN,Occludin,Inverse variance weighted,2,1.12 [0.98-1.27],0.0919136646866827,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.89 [0.78-1.02],0.0937582647886141,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.05 [0.99-1.12],0.0941915419040794,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.9 [0.8-1.02],0.0950149168575568,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.93 [0.85-1.01],0.095154839984279,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.08 [0.98-1.19],0.0995702192996273,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.89 [0.77-1.02],0.100819273058941,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL19,Interleukin-19,Inverse variance weighted,11,0.96 [0.91-1.01],0.101801360984293,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PI3,Elafin,Inverse variance weighted,10,0.95 [0.9-1.01],0.101915002418491,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSO,Cathepsin O,Inverse variance weighted,6,1.07 [0.99-1.15],0.102349441945875,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.96 [0.91-1.01],0.102677984855873,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.04 [0.99-1.1],0.103326217813714,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCG2,Secretogranin-2,Wald ratio,1,0.75 [0.52-1.06],0.103457926553801,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.95 [0.88-1.01],0.10365394959499,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.99-1.12],0.104004719034626,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.13 [0.97-1.31],0.104527599544526,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.09 [0.98-1.2],0.105563314363913,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EDN1,Endothelin-1,Inverse variance weighted,3,0.94 [0.87-1.01],0.106000026883763,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.94 [0.88-1.01],0.108553138002187,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.15 [0.97-1.37],0.109629717400412,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGA4,Pepsin A-4,Inverse variance weighted,2,1.2 [0.96-1.5],0.109843683936154,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.83 [0.66-1.04],0.111222951082351,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.96 [0.92-1.01],0.112582733775771,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.02 [0.99-1.05],0.112660625071878,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS9,Galectin-9,Inverse variance weighted,26,0.97 [0.94-1.01],0.11503339032762,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CFD,Complement factor D,Inverse variance weighted,11,1.04 [0.99-1.1],0.129972390201769,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN3,CCN family member 3,Inverse variance weighted,19,0.96 [0.92-1.01],0.134553571895112,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.96 [0.91-1.01],0.135027618346269,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.98 [0.96-1.01],0.135747556094507,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.93 [0.84-1.02],0.137121021561084,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP10,Stromelysin-2,Inverse variance weighted,22,1.03 [0.99-1.08],0.138788101739967,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.94 [0.86-1.02],0.140503417495826,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.07 [0.98-1.17],0.141170934389154,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.94 [0.87-1.02],0.142789810726862,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH3,Cadherin-3,Inverse variance weighted,2,0.87 [0.71-1.05],0.144603373575837,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.02 [0.99-1.04],0.146572712670957,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,1.13 [0.96-1.33],0.147576989218357,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD70,CD70 antigen,Inverse variance weighted,28,0.98 [0.95-1.01],0.153409603556124,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.9 [0.78-1.04],0.157385457778357,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.86 [0.7-1.06],0.157857910840572,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.9 [0.79-1.04],0.157959899734991,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CALB1,Calbindin,Inverse variance weighted,2,0.87 [0.72-1.06],0.158646082499439,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PENK,Proenkephalin-A,Inverse variance weighted,19,1.04 [0.99-1.09],0.161074731517745,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.98 [0.96-1.01],0.16387699574591,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.95 [0.88-1.02],0.166580345175144,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.03 [0.99-1.08],0.168328244271356,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MILR1,Allergin-1,Inverse variance weighted,33,1.01 [0.99-1.03],0.169240917903633,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.2 [0.92-1.56],0.174012853031639,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.17 [0.93-1.48],0.175442874142469,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS1,Galectin-1,Inverse variance weighted,6,1.03 [0.98-1.09],0.177727141279681,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.96 [0.91-1.02],0.182060721858266,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COLEC12,Collectin-12,Inverse variance weighted,11,1.05 [0.98-1.13],0.184239754821728,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.13 [0.94-1.36],0.184578331258897,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,UMOD,Uromodulin,Inverse variance weighted,29,0.99 [0.97-1.01],0.187341828252605,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.05 [0.97-1.14],0.189183629806186,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.92 [0.81-1.04],0.196827120632125,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.02 [0.99-1.05],0.19715362964112,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,0.95 [0.88-1.03],0.200214425133611,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Wald ratio,1,0.96 [0.91-1.02],0.201778282324775,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,0.97 [0.94-1.01],0.206030102045627,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.04 [0.98-1.09],0.206548765578468,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.95 [0.89-1.03],0.207491433717718,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRTN3,Myeloblastin,Inverse variance weighted,21,1.02 [0.99-1.06],0.21198102490356,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.09 [0.95-1.26],0.214947137578301,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.07 [0.96-1.2],0.215261920427928,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.04 [0.98-1.11],0.222876196610651,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.88 [0.72-1.08],0.225465826123957,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.87 [0.7-1.09],0.227116250826424,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.1 [0.94-1.29],0.227463417926259,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,0.97 [0.92-1.02],0.228288288168951,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.83 [0.62-1.12],0.228710428837671,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.98 [0.96-1.01],0.22907375660516,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.03 [0.98-1.09],0.232018654921117,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.05 [0.97-1.15],0.235048970277067,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL17C,Interleukin-17C,Inverse variance weighted,3,0.93 [0.82-1.05],0.236915563874667,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.98-1.09],0.244757924927474,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CALCA,Calcitonin,Inverse variance weighted,5,1.08 [0.95-1.23],0.246234922325599,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.03 [0.98-1.08],0.250015241571675,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN4,CCN family member 4,Inverse variance weighted,27,1.02 [0.99-1.05],0.252641331344856,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.98 [0.95-1.01],0.254190830083985,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.18 [0.89-1.55],0.256473499699453,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.95 [0.86-1.04],0.256611659159061,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.97 [0.91-1.03],0.257145583701992,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.88 [0.71-1.1],0.257324582532604,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TTR,Transthyretin,Inverse variance weighted,3,1.1 [0.93-1.28],0.258650593578529,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSM,Oncostatin-M,Wald ratio,1,0.87 [0.68-1.11],0.259096994150117,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.03 [0.98-1.07],0.261352624654149,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.04 [0.97-1.1],0.263611113754994,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AREG,Amphiregulin,Inverse variance weighted,3,1.06 [0.95-1.18],0.265319325861988,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANXA5,Annexin A5,Inverse variance weighted,2,0.91 [0.78-1.07],0.265666479459802,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.9 [0.75-1.08],0.266031711536336,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,0.99 [0.97-1.01],0.269583606866148,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.97 [0.93-1.02],0.274103026063669,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.06 [0.95-1.18],0.281378288255813,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.95 [0.86-1.04],0.282940409365385,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGF,Placenta growth factor,Inverse variance weighted,2,0.61 [0.24-1.52],0.286288074771589,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.02 [0.99-1.04],0.288838519786851,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BSG,Basigin,Wald ratio,1,1.07 [0.95-1.2],0.289222191130887,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.92 [0.79-1.07],0.29526774758648,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.93 [0.81-1.07],0.295267747586481,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.03 [0.97-1.1],0.299832366496411,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.03 [0.97-1.1],0.301419748195448,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PZP,Pregnancy zone protein,Inverse variance weighted,2,1.2 [0.85-1.71],0.302228999046011,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.03 [0.97-1.1],0.306746003509096,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,0.97 [0.91-1.03],0.30716152504627,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.99 [0.96-1.01],0.308010160272478,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.96-1.01],0.309218445850594,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.02 [0.98-1.05],0.31009459909325,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MDK,Midkine,Inverse variance weighted,4,1.06 [0.95-1.18],0.314103819646116,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.02 [0.98-1.06],0.319166973892658,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.12 [0.89-1.42],0.332262904089092,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.95 [0.84-1.06],0.336650460515935,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.98 [0.94-1.02],0.336772968187423,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ALCAM,CD166 antigen,Inverse variance weighted,6,1.05 [0.95-1.17],0.337629365156206,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.96-1.02],0.339575887955681,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.02 [0.98-1.07],0.345670112296447,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.97-1.01],0.347546577973208,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.97 [0.9-1.04],0.347835599927636,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.97-1.01],0.350855597667441,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.02 [0.98-1.05],0.355364215398605,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.05 [0.95-1.16],0.355703713840107,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,0.99 [0.96-1.01],0.356211440274202,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.88 [0.67-1.16],0.357218899865397,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.02 [0.98-1.06],0.358101342948632,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.96 [0.89-1.04],0.358126037352476,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.05 [0.95-1.17],0.360332246830454,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AGRN,Agrin,Inverse variance weighted,17,1.02 [0.97-1.08],0.368516510068129,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.89 [0.68-1.15],0.370289199431394,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.02 [0.97-1.07],0.370611079124479,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.98 [0.93-1.03],0.371016731064743,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.99 [0.97-1.01],0.37126954707476,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.02 [0.97-1.08],0.374803511550536,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.02 [0.98-1.07],0.376533710730989,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.97 [0.9-1.04],0.377304478184351,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.05 [0.94-1.17],0.377899610436873,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.96 [0.88-1.05],0.381992963870696,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.05 [0.94-1.18],0.382984963139763,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA3,Carbonic anhydrase 3,Inverse variance weighted,6,1.05 [0.95-1.16],0.384632263524912,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.95 [0.85-1.07],0.387052047894293,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.98 [0.94-1.02],0.388299459347184,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.01 [0.98-1.04],0.390521365409855,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SDC1,Syndecan-1,Inverse variance weighted,2,0.95 [0.84-1.07],0.392416325713436,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.05 [0.94-1.18],0.395037837847645,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C9,Complement component C9,Inverse variance weighted,5,1.06 [0.93-1.22],0.395959837547749,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.02 [0.98-1.06],0.39713434611948,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.98 [0.93-1.03],0.401009082052624,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPON1,Spondin-1,Inverse variance weighted,21,0.98 [0.93-1.03],0.403464116720497,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.01 [0.98-1.05],0.408827157789179,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.97-1.07],0.412812149782208,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.95 [0.83-1.08],0.414047332001555,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.02 [0.97-1.06],0.421447071535607,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.01 [0.98-1.05],0.428693763742574,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.94 [0.79-1.1],0.429184150899803,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.03 [0.96-1.1],0.431570716780354,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.99 [0.96-1.02],0.432172709611104,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.07 [0.91-1.25],0.434094803097651,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.97 [0.89-1.05],0.434646095708749,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAYN,Layilin,Inverse variance weighted,20,1.02 [0.97-1.07],0.435036962989563,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.96 [0.87-1.06],0.436444160173628,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PAEP,Glycodelin,Inverse variance weighted,26,0.99 [0.96-1.02],0.440240546373262,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.01 [0.98-1.05],0.44087703141815,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSLN,Mesothelin,Inverse variance weighted,25,0.99 [0.96-1.02],0.440970694361757,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.98 [0.94-1.03],0.441747629090923,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NECTIN2,Nectin-2,Inverse variance weighted,5,0.98 [0.92-1.04],0.442416367434995,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.98 [0.92-1.04],0.442835860222486,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.98 [0.94-1.03],0.446673591978692,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.02 [0.97-1.07],0.449057890327534,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.07 [0.9-1.25],0.451274100342428,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK4,Kallikrein-4,Inverse variance weighted,17,0.98 [0.94-1.03],0.451326581862219,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.98 [0.93-1.03],0.451979768335195,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.02 [0.97-1.06],0.455412300991974,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.04 [0.94-1.15],0.455505575293863,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.96 [0.87-1.07],0.459294678497046,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,0.99 [0.98-1.01],0.460923162649023,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.98 [0.93-1.04],0.462950554757103,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.04 [0.94-1.14],0.466045199047126,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.02 [0.97-1.07],0.467709287770219,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.98 [0.91-1.04],0.468016197369723,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.99 [0.95-1.02],0.46846373400725,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.18 [0.75-1.86],0.472579722719508,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.97-1.07],0.477053959604486,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.98 [0.94-1.03],0.478479900174532,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.98-1.04],0.480856676535292,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.97 [0.89-1.06],0.488810534861764,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.01 [0.98-1.05],0.491200270305296,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MB,Myoglobin,Wald ratio,1,1.17 [0.75-1.82],0.493835452952222,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.01 [0.98-1.04],0.498519720209038,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.01 [0.98-1.03],0.498795506879318,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TMSB10,Thymosin beta-10,Wald ratio,1,0.91 [0.68-1.21],0.505064625859369,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.07 [0.88-1.29],0.505371685672956,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP3,Stromelysin-1,Inverse variance weighted,34,1.01 [0.98-1.05],0.506242369815868,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.94 [0.79-1.13],0.506758215568016,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.99 [0.95-1.02],0.507561547917405,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD276,CD276 antigen,Inverse variance weighted,20,1.01 [0.98-1.04],0.51008447221822,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.07 [0.87-1.32],0.51066916550816,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DSC2,Desmocollin-2,Inverse variance weighted,9,0.98 [0.93-1.04],0.512009081355555,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.04 [0.91-1.19],0.519540657391595,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.93-1.04],0.51958994037695,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.98-1.04],0.521737873926027,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.98-1.04],0.523495976499205,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.05 [0.9-1.22],0.525640323212656,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.02 [0.97-1.07],0.525947102457853,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,1.01 [0.97-1.05],0.527188138065658,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSV,Cathepsin L2,Inverse variance weighted,11,0.98 [0.92-1.04],0.527666216417328,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSF3R,Granulocyte colony-stimulating factor receptor,Inverse variance weighted,9,0.99 [0.97-1.02],0.532788944342799,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.98 [0.93-1.04],0.533405318194501,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPON2,Spondin-2,Inverse variance weighted,4,0.98 [0.91-1.05],0.537135824836778,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.97 [0.87-1.07],0.537902630116667,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.02 [0.96-1.09],0.537914046600311,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BCAN,Brevican core protein,Inverse variance weighted,3,0.98 [0.91-1.05],0.544639317220918,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.94-1.03],0.545614396372056,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REN,Renin,Inverse variance weighted,4,0.98 [0.92-1.05],0.545750155823782,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.06 [0.88-1.28],0.547770879050523,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.95-1.1],0.550480176341267,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.98-1.03],0.550764851067417,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,1.02 [0.96-1.08],0.551037958167725,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.02 [0.96-1.07],0.556277798273566,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.99 [0.94-1.03],0.557794734064863,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.01 [0.97-1.06],0.559534941133207,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.98 [0.94-1.04],0.561306801595162,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.96 [0.85-1.09],0.568511301151063,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD27,CD27 antigen,Inverse variance weighted,9,1.02 [0.95-1.09],0.570424536803182,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.12 [0.75-1.68],0.571741621532505,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FETUB,Fetuin-B,Inverse variance weighted,20,1.01 [0.97-1.06],0.573639359650767,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRSS8,Prostasin,Inverse variance weighted,5,0.97 [0.86-1.09],0.57473037856873,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.02 [0.95-1.1],0.578311856617143,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.96 [0.81-1.12],0.581146898154029,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VWC2,Brorin,Inverse variance weighted,22,0.99 [0.94-1.03],0.584615954065962,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,0.97 [0.89-1.07],0.585086124220759,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.99 [0.97-1.02],0.586921506253497,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.92 [0.68-1.25],0.588148678810323,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TSPAN1,Tetraspanin-1,Inverse variance weighted,2,1.1 [0.78-1.54],0.588245370050768,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RSPO1,R-spondin-1,Inverse variance weighted,5,1.02 [0.95-1.09],0.589487611454756,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.98 [0.93-1.04],0.58980403413819,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNC,Tenascin,Inverse variance weighted,12,1.02 [0.95-1.09],0.594626156574599,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NFASC,Neurofascin,Inverse variance weighted,15,1.01 [0.97-1.05],0.595689151098951,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFNL1,Interferon lambda-1,Wald ratio,1,0.9 [0.61-1.32],0.595960790416428,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.96 [0.81-1.13],0.597795932148091,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.11 [0.75-1.65],0.602409234482117,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.97 [0.86-1.09],0.603654054079855,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,0.99 [0.93-1.04],0.608380853620101,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.97 [0.88-1.07],0.608416373882018,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.01 [0.98-1.03],0.608769786927709,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.01 [0.98-1.03],0.617124901749754,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.02 [0.93-1.13],0.617783538536512,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.98 [0.91-1.06],0.619731994533843,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.03 [0.92-1.16],0.620787705761106,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.99 [0.94-1.04],0.622047503227921,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,1 [0.99-1.02],0.631599142178591,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.93 [0.68-1.26],0.631773523988882,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.98 [0.89-1.07],0.633634556565967,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.01 [0.96-1.07],0.634743555841807,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.92 [0.64-1.31],0.635307439062711,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.95-1.03],0.637564084884517,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.11 [0.73-1.68],0.638980006630747,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,0.99 [0.93-1.05],0.642111032868565,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DSG2,Desmoglein-2,Inverse variance weighted,11,1.01 [0.95-1.08],0.642299074006884,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.98-1.03],0.643530604171956,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.01 [0.96-1.07],0.644251676749263,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.96 [0.82-1.13],0.653862703119894,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.98 [0.92-1.06],0.654676987233962,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.03 [0.91-1.16],0.658191561340037,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.02 [0.94-1.09],0.658332727274336,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.99 [0.97-1.02],0.659016774958729,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.96 [0.79-1.17],0.661263000259658,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AMBP,Protein AMBP,Inverse variance weighted,3,1.02 [0.92-1.14],0.664495270949543,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.99 [0.96-1.03],0.665534570597075,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.92 [0.65-1.32],0.668878027113928,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.95 [0.76-1.19],0.669586101161019,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.94 [0.7-1.25],0.669757930567531,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.97 [0.87-1.1],0.671428140465289,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.98 [0.9-1.07],0.67909196865316,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.01 [0.97-1.04],0.679579791535467,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.98 [0.87-1.09],0.680344095035904,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.01 [0.97-1.05],0.681502536923177,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK10,Kallikrein-10,Inverse variance weighted,15,0.99 [0.92-1.06],0.683754594749742,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.99 [0.97-1.02],0.683990350248927,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.02 [0.94-1.09],0.68505158266787,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.97 [0.83-1.13],0.68784772785366,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.99 [0.94-1.04],0.690414721027739,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.03 [0.9-1.17],0.690899403604693,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.92 [0.63-1.36],0.691030957651335,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANG,Angiogenin,Inverse variance weighted,19,0.99 [0.96-1.03],0.693286078461861,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RSPO3,R-spondin-3,Inverse variance weighted,6,1.03 [0.88-1.21],0.6959266914205,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD83,CD83 antigen,Inverse variance weighted,5,0.98 [0.9-1.07],0.697889456749685,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.98 [0.91-1.07],0.69856062562519,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.02 [0.91-1.15],0.700232700596513,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.99 [0.96-1.03],0.703992837478945,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL15,Interleukin-15,Wald ratio,1,1.35 [0.29-6.36],0.704221096617627,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.97 [0.82-1.14],0.70464806616355,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.99 [0.95-1.04],0.705429936152058,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL10,Interleukin-10,Wald ratio,1,0.97 [0.82-1.14],0.708477403821736,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.98 [0.87-1.1],0.709197433216488,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.99 [0.94-1.04],0.710545888183512,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.02 [0.93-1.12],0.712394768103994,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1.01 [0.96-1.07],0.71493906873845,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.05 [0.82-1.34],0.715898402630325,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RETN,Resistin,Inverse variance weighted,9,0.99 [0.95-1.04],0.716131646406217,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.96 [0.78-1.18],0.717729160942941,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.98 [0.86-1.11],0.718730908077216,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.97 [0.83-1.14],0.719240766165783,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1 [0.99-1.02],0.723292955268754,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.97 [0.81-1.16],0.7237728796401,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH1,Cadherin-1,Wald ratio,1,0.94 [0.65-1.34],0.72557220347661,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THBD,Thrombomodulin,Inverse variance weighted,5,1.01 [0.94-1.1],0.72702913924686,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.99 [0.92-1.06],0.727204805784619,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,0.99 [0.95-1.03],0.730611266668682,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.99 [0.93-1.05],0.731667098474563,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.03 [0.88-1.2],0.732398922678082,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.98 [0.88-1.1],0.733648207938329,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.05 [0.81-1.36],0.737680193169725,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.97-1.04],0.737967270116211,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,1 [0.98-1.03],0.741571839303162,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.01 [0.97-1.04],0.741771173909427,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.99 [0.92-1.06],0.742566656582274,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.97 [0.8-1.17],0.742831603334878,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.01 [0.93-1.1],0.743171754678228,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.01 [0.95-1.07],0.747068274480476,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANXA10,Annexin A10,Wald ratio,1,0.95 [0.68-1.32],0.747449164042107,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1 [0.97-1.02],0.750195804271055,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.99 [0.96-1.03],0.751166060429643,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.06 [0.74-1.51],0.752413448078521,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.98 [0.88-1.1],0.755822832077562,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.97-1.02],0.761430276992396,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GSN,Gelsolin,Inverse variance weighted,5,1.02 [0.89-1.16],0.762783478474473,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,0.99 [0.91-1.07],0.764358514087074,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.97 [0.78-1.2],0.766565015591355,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GUCA2A,Guanylin,Inverse variance weighted,9,1.01 [0.94-1.09],0.768606984809797,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,1 [0.99-1.02],0.768645177033235,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.97 [0.82-1.16],0.773212774414269,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OGN,Mimecan,Inverse variance weighted,30,1 [0.96-1.03],0.774231830569461,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.02 [0.88-1.18],0.775698086452262,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.99 [0.95-1.04],0.778549177909918,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CX3CL1,Fractalkine,Inverse variance weighted,9,0.99 [0.92-1.07],0.779922806714962,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LCN15,Lipocalin-15,Inverse variance weighted,20,1 [0.98-1.03],0.786696444409894,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.99 [0.94-1.05],0.787102738947302,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.02 [0.89-1.17],0.787610603070763,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.01 [0.96-1.05],0.789525174803167,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.01 [0.91-1.13],0.79129674677671,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRH,Corticoliberin,Inverse variance weighted,11,0.99 [0.94-1.04],0.795532955556655,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.97 [0.76-1.24],0.798438687321724,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.01 [0.93-1.1],0.799375518229932,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.01 [0.91-1.14],0.802735942412817,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,1.02 [0.9-1.15],0.802909427623014,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.99 [0.93-1.06],0.80456718183725,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.95 [0.61-1.47],0.807749546965229,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THBS2,Thrombospondin-2,Inverse variance weighted,16,1 [0.97-1.05],0.808086387224322,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.01 [0.91-1.13],0.813223354275281,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.99 [0.88-1.1],0.814553750865223,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1 [0.96-1.04],0.81589073893067,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XCL1,Lymphotactin,Inverse variance weighted,31,1 [0.98-1.03],0.818883954714869,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.95-1.05],0.821769327578439,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPPC,C-type natriuretic peptide,Wald ratio,1,0.96 [0.64-1.43],0.82282848206948,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.01 [0.9-1.15],0.823437475601327,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AFP,Alpha-fetoprotein,Inverse variance weighted,5,1.01 [0.92-1.11],0.824542768148143,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.97-1.03],0.827661693303268,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPT,Dermatopontin,Inverse variance weighted,21,1 [0.96-1.05],0.827870030496575,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.02 [0.86-1.21],0.830408774593069,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHGA,Chromogranin-A,Inverse variance weighted,3,1.01 [0.93-1.1],0.830797563027522,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1 [0.97-1.04],0.832037885871351,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.01 [0.88-1.17],0.835024113991253,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1 [0.96-1.03],0.836061362566474,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.99 [0.94-1.05],0.836407353677482,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.98-1.03],0.837171757836255,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,0.99 [0.91-1.08],0.838325546504763,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.99 [0.89-1.1],0.843404953189511,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPO,Erythropoietin,Inverse variance weighted,5,0.98 [0.8-1.2],0.844231840437662,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.98-1.02],0.845020071290998,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD46,Membrane cofactor protein,Wald ratio,1,1.02 [0.84-1.23],0.846018731844458,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NRP1,Neuropilin-1,Inverse variance weighted,12,1 [0.96-1.05],0.847198443301228,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP7,Matrilysin,Inverse variance weighted,13,0.99 [0.93-1.06],0.848177426209989,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.98-1.02],0.849218568132286,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,3,1.01 [0.92-1.11],0.854138232796777,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.03 [0.78-1.35],0.854600625798222,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.99 [0.9-1.09],0.856059033788382,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.99 [0.86-1.14],0.85848957663332,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NECTIN4,Nectin-4,Inverse variance weighted,7,1 [0.95-1.05],0.860081685847923,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPP1,Osteopontin,Inverse variance weighted,8,1.01 [0.89-1.14],0.868604448264884,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1 [0.97-1.02],0.868799362296347,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD302,CD302 antigen,Inverse variance weighted,9,1.01 [0.94-1.07],0.869116498301687,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PALM2,Paralemmin-2,Inverse variance weighted,8,0.99 [0.92-1.07],0.870187136421939,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEPTIN8,Septin-8,Inverse variance weighted,2,1.01 [0.86-1.2],0.871880793857367,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SNCG,Gamma-synuclein,Inverse variance weighted,36,1 [0.98-1.03],0.876090560898573,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.01 [0.92-1.1],0.876407979179332,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.99 [0.91-1.08],0.881429519237566,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.97 [0.61-1.53],0.882453382520571,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PEPD,Xaa-Pro dipeptidase,Inverse variance weighted,12,1 [0.96-1.04],0.882594566819518,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1 [0.95-1.04],0.882871759012594,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1 [0.94-1.07],0.883228593659354,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1 [0.96-1.05],0.885816749045868,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.99 [0.85-1.16],0.886989640422279,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.01 [0.87-1.17],0.887731491320203,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FBLN2,Fibulin-2,Inverse variance weighted,11,1 [0.95-1.04],0.888020731762019,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTN,Pleiotrophin,Inverse variance weighted,4,0.99 [0.81-1.2],0.890360446681442,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MATN2,Matrilin-2,Inverse variance weighted,18,1 [0.94-1.05],0.89397969919989,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1 [0.96-1.05],0.894711210211695,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18,Interleukin-18,Inverse variance weighted,16,1.01 [0.91-1.11],0.896130877594859,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.02 [0.78-1.33],0.896137280102284,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK8,Kallikrein-8,Inverse variance weighted,12,1 [0.95-1.05],0.899793537175761,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1 [0.96-1.05],0.907434309600686,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1 [0.96-1.03],0.910839975394849,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1 [0.97-1.03],0.911124313812746,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3D,Protein FAM3D,Inverse variance weighted,17,1 [0.94-1.07],0.914460210894944,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1 [0.95-1.06],0.916270730843375,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PSAP,Prosaposin,Inverse variance weighted,5,1.01 [0.91-1.11],0.917248579640971,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD160,CD160 antigen,Inverse variance weighted,11,1 [0.96-1.04],0.925670233774244,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.99 [0.87-1.13],0.926003112703518,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,26,1 [0.98-1.02],0.928847470640213,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SELENOP,Selenoprotein P,Inverse variance weighted,2,0.99 [0.85-1.16],0.930512551300974,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN5,CCN family member 5,Inverse variance weighted,8,1.01 [0.86-1.18],0.933240837779884,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1 [0.93-1.07],0.933640748977342,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1 [0.95-1.06],0.938098774232523,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1 [0.95-1.05],0.940911661047633,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MPO,Myeloperoxidase,Inverse variance weighted,11,1 [0.95-1.06],0.941595242094921,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,1 [0.95-1.04],0.942260832888027,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSL,Cathepsin L1,Wald ratio,1,1.01 [0.7-1.46],0.945770124123649,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPOCK1,Testican-1,Inverse variance weighted,6,1 [0.91-1.1],0.947953817809123,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1 [0.97-1.04],0.948446485826402,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1 [0.97-1.03],0.949745023540219,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1 [0.95-1.05],0.951588054411957,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1 [0.96-1.04],0.954702518373745,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SDC4,Syndecan-4,Inverse variance weighted,8,1 [0.92-1.09],0.955205375671598,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1 [0.97-1.03],0.957792402155794,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.99 [0.83-1.2],0.95782718156254,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK11,Kallikrein-11,Inverse variance weighted,6,1 [0.95-1.05],0.961235777590018,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1 [0.82-1.23],0.966151835314024,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.99 [0.67-1.46],0.967189830538489,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1 [0.9-1.12],0.968219190968966,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1 [0.94-1.07],0.969949321878858,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA11,Serpin A11,Inverse variance weighted,31,1 [0.97-1.03],0.972163413412979,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1 [0.9-1.1],0.972178504456078,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CNTN5,Contactin-5,Inverse variance weighted,28,1 [0.97-1.03],0.972370333852007,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1 [0.82-1.22],0.979095599267298,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3B,Protein FAM3B,Inverse variance weighted,18,1 [0.97-1.03],0.979539172852587,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.99 [0.58-1.69],0.980630571850582,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1 [0.76-1.31],0.983780962601665,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1 [0.86-1.17],0.988821894039968,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ELN,Elastin,Inverse variance weighted,2,1 [0.8-1.26],0.988834067139595,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1 [0.94-1.06],0.99063013823119,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1 [0.92-1.09],0.99070742824559,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1 [0.91-1.1],0.99413819020249,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1 [0.95-1.06],0.99518661339656,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1 [0.89-1.12],0.997564602857987,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DRAXIN,Draxin,Inverse variance weighted,13,1 [0.97-1.04],0.998335145829435,cis
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL15,Interleukin-15,Inverse variance weighted,35,0.91 [0.87-0.95],9.30935819411262e-05,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.93 [0.88-0.97],0.000724138851216844,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL19,Interleukin-19,Inverse variance weighted,10,0.92 [0.88-0.97],0.00105775254223451,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.58 [0.4-0.82],0.0020848681686378,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RSPO1,R-spondin-1,Inverse variance weighted,8,0.86 [0.78-0.95],0.00211618331217754,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.87 [0.8-0.95],0.00250955171828748,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.84 [0.74-0.95],0.00611909070893216,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.17 [1.05-1.31],0.00627880021180716,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.89 [0.82-0.97],0.00992855425821525,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.84 [0.74-0.96],0.0122476709340352,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.88 [0.8-0.97],0.0123186364218387,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18,Interleukin-18,Inverse variance weighted,26,0.94 [0.89-0.99],0.0126756200761545,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.74 [0.58-0.94],0.0157377399973023,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.89 [0.81-0.98],0.0159541919342998,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.09 [1.02-1.17],0.0175702092059682,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.71 [0.53-0.95],0.0193898806373298,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,0.93 [0.87-0.99],0.0200284347072777,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.86 [0.75-0.98],0.021776903243002,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.73 [0.55-0.96],0.0220309393031061,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP7,Matrilysin,Wald ratio,1,1.2 [1.03-1.39],0.0221213415749339,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RSPO3,R-spondin-3,Inverse variance weighted,5,0.85 [0.73-0.98],0.0232100342047629,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.89 [0.8-0.99],0.0254524353845485,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.93 [0.87-0.99],0.0261400480632513,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGF,Placenta growth factor,Inverse variance weighted,5,0.86 [0.75-0.98],0.0263253617275876,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.8 [0.65-0.97],0.027400026034971,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CALB1,Calbindin,Inverse variance weighted,9,0.89 [0.8-0.99],0.0392481332384331,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.84 [0.72-0.99],0.0397724663562326,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.06 [1-1.11],0.0416353846270299,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK4,Kallikrein-4,Inverse variance weighted,5,1.24 [1.01-1.53],0.0420640441217937,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.8 [0.64-1],0.0458552838721116,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,UMOD,Uromodulin,Inverse variance weighted,34,0.94 [0.89-1],0.0461095591314034,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.83 [0.68-1],0.046340717439198,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REN,Renin,Inverse variance weighted,8,0.86 [0.74-1],0.0469036493693132,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.97 [0.95-1],0.0510476312918047,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.03 [1-1.07],0.0517218262763403,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.16 [1-1.34],0.0533689183533438,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.27 [1-1.62],0.0536897368920086,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.76 [0.57-1],0.053988183893114,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.14 [1-1.3],0.0549179410875669,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.08 [1-1.18],0.0554185240417358,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP10,Stromelysin-2,Wald ratio,1,0.66 [0.43-1.01],0.0567409015343002,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NRP1,Neuropilin-1,Inverse variance weighted,14,1.1 [1-1.21],0.0575982403681902,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN3,CCN family member 3,Inverse variance weighted,17,0.95 [0.89-1],0.0591120404635069,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.86 [0.74-1.01],0.0694067162798278,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CAPG,Macrophage-capping protein,Wald ratio,1,1.33 [0.98-1.82],0.0703056674973285,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.95 [0.9-1],0.0719331301172733,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CFD,Complement factor D,Wald ratio,1,1.38 [0.97-1.96],0.0722020550198908,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.9 [0.8-1.01],0.072890470202271,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PI3,Elafin,Inverse variance weighted,18,0.96 [0.91-1.01],0.0777462308389537,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.87 [0.75-1.02],0.078670671872908,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.99 [0.97-1],0.0789989365119696,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.12 [0.99-1.28],0.0810694259535698,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.38 [0.96-1.97],0.0812006540904444,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.91 [0.82-1.01],0.0848792034533033,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.94 [0.88-1.01],0.0855825693614642,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNC,Tenascin,Inverse variance weighted,57,1.02 [1-1.05],0.086824986338403,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.43 [0.95-2.14],0.0874961022920055,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.82 [0.65-1.03],0.0884606544764804,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AFP,Alpha-fetoprotein,Inverse variance weighted,67,0.97 [0.93-1.01],0.0897401411261354,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.86 [0.73-1.02],0.0901615186756167,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.21 [0.97-1.5],0.0911339088602423,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH2,Cadherin-2,Inverse variance weighted,21,0.94 [0.88-1.01],0.0917316715702036,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.89 [0.77-1.02],0.0939755553398854,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.93 [0.85-1.01],0.095154839984279,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CX3CL1,Fractalkine,Inverse variance weighted,12,0.89 [0.78-1.02],0.0963317940602696,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GUCA2A,Guanylin,Inverse variance weighted,7,0.89 [0.78-1.02],0.0966469813421768,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,POF1B,Protein POF1B,Inverse variance weighted,4,0.88 [0.76-1.02],0.097558103780805,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.86 [0.71-1.03],0.0996790696602035,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.08 [0.98-1.18],0.102807817336789,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.09 [0.98-1.2],0.102963088629309,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MDK,Midkine,Inverse variance weighted,14,1.09 [0.98-1.21],0.105572575378936,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.41 [0.93-2.14],0.109802804726807,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.87 [0.74-1.03],0.109969542980389,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.89 [0.78-1.03],0.111227270114774,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.96 [0.91-1.01],0.112191508723832,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PALM,Paralemmin-1,Inverse variance weighted,4,1.14 [0.97-1.33],0.115270951216545,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.05 [0.99-1.11],0.118329871304611,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD48,CD48 antigen,Inverse variance weighted,14,0.93 [0.84-1.02],0.118458507046222,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.93-1.01],0.123937087794388,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.89 [0.77-1.03],0.129301400938701,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.06 [0.98-1.15],0.132906881021444,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.04 [0.99-1.08],0.134506796841813,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BRK1,Protein BRICK1,Inverse variance weighted,10,0.95 [0.88-1.02],0.135134042950101,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.22 [0.94-1.59],0.136353099267107,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MILR1,Allergin-1,Inverse variance weighted,43,1.01 [1-1.04],0.13674687095336,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.04 [0.99-1.09],0.137443240313942,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.08 [0.98-1.19],0.138468288548416,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.03 [0.99-1.06],0.138939771406217,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.98 [0.95-1.01],0.139061764105363,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.06 [0.98-1.14],0.14104040318942,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.99-1.05],0.144457514359339,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.8 [0.59-1.08],0.144904655193404,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.37 [0.9-2.08],0.146080755642308,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.05 [0.98-1.13],0.153311739190083,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.95-1.01],0.153672226004304,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.13 [0.96-1.33],0.155255886002093,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.03 [0.99-1.08],0.156693679295921,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.94 [0.85-1.03],0.161633590900588,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PEPD,Xaa-Pro dipeptidase,Inverse variance weighted,14,0.95 [0.88-1.02],0.162255236038168,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH3,Cadherin-3,Inverse variance weighted,10,1.07 [0.97-1.18],0.16581329372789,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.94 [0.86-1.03],0.166937999983107,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.93 [0.83-1.03],0.170795938973871,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.16 [0.94-1.43],0.171041232414202,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.93 [0.84-1.03],0.171327521209652,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1.06 [0.98-1.15],0.173936337396839,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.9 [0.77-1.05],0.17803579954628,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.96 [0.9-1.02],0.178050969480768,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.95 [0.89-1.02],0.178251178751257,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,3,1.24 [0.91-1.7],0.179228819733462,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.9 [0.76-1.06],0.188627078676293,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.95 [0.88-1.03],0.189115348983525,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.12 [0.94-1.33],0.189390292142111,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN4,CCN family member 4,Inverse variance weighted,29,0.98 [0.94-1.01],0.190494001725933,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.12 [0.94-1.33],0.191706985679862,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.95 [0.88-1.03],0.193387283001816,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CST3,Cystatin-C,Inverse variance weighted,3,1.16 [0.93-1.45],0.198961714500424,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.96 [0.9-1.02],0.201000432722386,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.98-1.09],0.205798113809518,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,35,1.03 [0.99-1.07],0.213897729287254,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAYN,Layilin,Inverse variance weighted,3,1.16 [0.92-1.46],0.21400609853074,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.93 [0.83-1.04],0.215078786230014,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LEP,Leptin,Inverse variance weighted,4,0.86 [0.68-1.09],0.217214139648257,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AMBP,Protein AMBP,Inverse variance weighted,5,1.09 [0.95-1.24],0.220058262279759,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.06 [0.97-1.16],0.220463041736466,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,0.96 [0.91-1.02],0.22427290398933,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.91 [0.79-1.06],0.224426647889684,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.95 [0.88-1.03],0.226187902580126,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FETUB,Fetuin-B,Inverse variance weighted,5,1.12 [0.93-1.34],0.230864626188839,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.17 [0.9-1.51],0.232523579953842,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.06 [0.96-1.18],0.237588664698869,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.97 [0.93-1.02],0.237750020429843,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.21 [0.88-1.66],0.23850020628831,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VWC2,Brorin,Inverse variance weighted,12,0.94 [0.84-1.04],0.239348437377716,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSLN,Mesothelin,Inverse variance weighted,11,1.07 [0.96-1.19],0.240818622093176,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEPTIN8,Septin-8,Inverse variance weighted,4,0.91 [0.78-1.06],0.241745443098609,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,0.91 [0.78-1.06],0.2426412350297,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.21 [0.88-1.67],0.245045630482114,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.94 [0.84-1.05],0.246278007316173,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.93 [0.82-1.05],0.248510639487117,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA3,Carbonic anhydrase 3,Inverse variance weighted,10,0.94 [0.86-1.04],0.25278444099082,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.02 [0.99-1.05],0.255301969193741,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.02 [0.98-1.06],0.259141771173995,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.05 [0.96-1.16],0.260199882283083,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.96 [0.89-1.03],0.261152694969974,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,1.02 [0.99-1.04],0.261446512190568,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.95 [0.88-1.04],0.262831604509982,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1.02 [0.99-1.05],0.264763018039538,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.81 [0.56-1.18],0.266268120070846,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PENK,Proenkephalin-A,Inverse variance weighted,15,1.05 [0.96-1.15],0.266471314023736,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.95 [0.86-1.04],0.268203558647399,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD83,CD83 antigen,Inverse variance weighted,14,0.93 [0.81-1.06],0.26927842379847,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.88 [0.71-1.1],0.271382932761262,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.05 [0.96-1.15],0.271517564374894,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C7,Complement component C7,Inverse variance weighted,26,1.02 [0.99-1.05],0.271981582447898,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.93 [0.82-1.06],0.273958607255779,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,0.96 [0.9-1.03],0.274136034748593,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.97-1.01],0.274442632614767,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NECTIN4,Nectin-4,Inverse variance weighted,4,0.9 [0.74-1.09],0.276956727535713,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.29 [0.81-2.05],0.27912834552056,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.96 [0.9-1.03],0.280557223698265,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.95 [0.87-1.04],0.283917862169259,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.18 [0.87-1.6],0.284330677003418,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.07 [0.95-1.21],0.286435388403354,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.09 [0.93-1.27],0.286967633125357,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.94 [0.84-1.05],0.287455754285022,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.88 [0.69-1.12],0.288439591496703,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1.04 [0.96-1.13],0.290341503094346,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.87 [0.68-1.12],0.294417173897208,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.98 [0.95-1.02],0.298962365913835,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DRAXIN,Draxin,Inverse variance weighted,25,0.97 [0.91-1.03],0.30032606983088,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.08 [0.93-1.26],0.301844479321295,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,0.93 [0.82-1.06],0.302662248480106,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.25 [0.82-1.91],0.304466818177093,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PGA4,Pepsin A-4,Inverse variance weighted,7,0.93 [0.81-1.07],0.311531844661963,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.89 [0.72-1.11],0.312117748108799,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.06 [0.95-1.18],0.313243182880564,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC3B,Tetranectin,Inverse variance weighted,2,0.86 [0.63-1.16],0.31819506910015,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.85 [0.62-1.17],0.320221793474003,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.98 [0.95-1.02],0.32708668920887,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PSAP,Prosaposin,Inverse variance weighted,13,0.97 [0.92-1.03],0.329543007205856,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSO,Cathepsin O,Inverse variance weighted,19,1.03 [0.97-1.08],0.33008975064338,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GRN,Progranulin,Inverse variance weighted,46,1.02 [0.98-1.05],0.330686188220515,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS9,Galectin-9,Inverse variance weighted,36,0.98 [0.95-1.02],0.332510071485766,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.06 [0.95-1.18],0.333488680179921,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD302,CD302 antigen,Inverse variance weighted,11,0.96 [0.88-1.04],0.335164412027178,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PAEP,Glycodelin,Inverse variance weighted,29,0.99 [0.96-1.01],0.337373371560465,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.95 [0.86-1.05],0.337684033438027,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.98 [0.94-1.02],0.337744057750762,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK8,Kallikrein-8,Inverse variance weighted,5,0.89 [0.71-1.12],0.33824467989044,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.03 [0.97-1.1],0.340638391398285,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSL,Cathepsin L1,Inverse variance weighted,29,1.03 [0.97-1.09],0.345743242196275,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XG,Glycoprotein Xg,Inverse variance weighted,2,0.87 [0.66-1.16],0.347509828875253,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NFASC,Neurofascin,Inverse variance weighted,6,0.93 [0.79-1.09],0.351306170463879,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.07 [0.92-1.24],0.355409047186864,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.02 [0.97-1.08],0.355618600654321,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.92 [0.78-1.09],0.355771939263355,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSV,Cathepsin L2,Inverse variance weighted,34,0.98 [0.93-1.03],0.358230553218066,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,1.05 [0.95-1.16],0.358680095868896,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,0.95 [0.85-1.06],0.364323016749545,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.07 [0.93-1.24],0.365099934602399,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.98 [0.94-1.02],0.36776393753586,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.89 [0.68-1.16],0.371196998596887,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK10,Kallikrein-10,Wald ratio,1,0.82 [0.53-1.27],0.376401402908441,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RETN,Resistin,Inverse variance weighted,19,1.04 [0.95-1.14],0.379136960807737,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.96 [0.89-1.05],0.380108810704936,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.93 [0.8-1.09],0.382601665980595,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CTSS,Cathepsin S,Inverse variance weighted,7,1.06 [0.93-1.19],0.385198146636467,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.93 [0.78-1.1],0.388090712646509,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.97 [0.92-1.03],0.389217121688153,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.94 [0.81-1.09],0.393150062269022,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.97 [0.9-1.04],0.398900419422292,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSF3R,Granulocyte colony-stimulating factor receptor,Inverse variance weighted,8,0.96 [0.87-1.06],0.399115606038994,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTN,Pleiotrophin,Inverse variance weighted,3,1.16 [0.82-1.66],0.399262013351541,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.91 [0.73-1.14],0.400330915734405,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.94 [0.82-1.08],0.402070444932055,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.98 [0.95-1.02],0.403431137530277,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.94 [0.81-1.09],0.405313544799053,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.04 [0.95-1.15],0.406007251536568,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA11,Serpin A11,Inverse variance weighted,14,0.95 [0.85-1.07],0.406863730710927,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.92 [0.75-1.13],0.412610231223678,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSTB,Cystatin-B,Inverse variance weighted,23,1.01 [0.98-1.05],0.415766103429931,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.96 [0.86-1.07],0.416160473304105,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.99 [0.95-1.02],0.416907150885137,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.18 [0.79-1.78],0.417860256570732,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.9 [0.7-1.16],0.418858891950326,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,WNT9A,Protein Wnt-9a,Wald ratio,1,1.21 [0.76-1.94],0.420258215295976,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RGMB,RGM domain family member B,Inverse variance weighted,5,1.09 [0.88-1.34],0.421334591326214,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.03 [0.95-1.13],0.423514719164091,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.95 [0.85-1.07],0.424693908327864,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.96 [0.86-1.07],0.430549255877075,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.07 [0.9-1.28],0.431553002052066,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.92 [0.74-1.14],0.434319924471033,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.11 [0.85-1.44],0.436590783770176,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.97 [0.88-1.05],0.436799065042678,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1.11 [0.86-1.43],0.437817507207512,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.94 [0.81-1.09],0.441204667359396,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.97 [0.9-1.05],0.443949150345738,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.03 [0.95-1.13],0.446012271716256,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.94 [0.8-1.11],0.446577703100546,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.99 [0.97-1.01],0.446911918216619,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.9 [0.68-1.18],0.447981582278268,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DSC2,Desmocollin-2,Inverse variance weighted,16,0.98 [0.93-1.03],0.448786269664867,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.02 [0.97-1.06],0.452323262427858,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.99 [0.95-1.02],0.458204784770541,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.97 [0.91-1.05],0.461044077950553,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.97 [0.89-1.06],0.462486103668658,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.02 [0.96-1.09],0.463860996669515,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.94 [0.79-1.11],0.464908871944582,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.95 [0.83-1.09],0.466615008480691,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.03 [0.96-1.1],0.46753693399267,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS3,Galectin-3,Inverse variance weighted,15,1.03 [0.95-1.12],0.473191391216885,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.03 [0.94-1.13],0.474104712161618,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.03 [0.95-1.11],0.474484834350644,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.07 [0.88-1.31],0.475056669091762,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DSG2,Desmoglein-2,Inverse variance weighted,22,0.98 [0.93-1.03],0.475331454969232,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.03 [0.95-1.12],0.475659184982646,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.04 [0.93-1.17],0.476547052804886,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.94 [0.8-1.11],0.482042167509822,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.95 [0.83-1.09],0.48286795584246,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.03 [0.95-1.12],0.482869378535077,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.02 [0.96-1.09],0.483003172878765,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.01 [0.97-1.06],0.483483787634629,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CDH1,Cadherin-1,Inverse variance weighted,16,1.03 [0.95-1.12],0.484555328218022,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.03 [0.94-1.13],0.485560453598912,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.98 [0.94-1.03],0.48904672010614,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD27,CD27 antigen,Inverse variance weighted,9,0.95 [0.82-1.1],0.492109117127672,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.91 [0.69-1.19],0.492899518801439,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.96 [0.87-1.07],0.495884457472803,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.03 [0.95-1.11],0.496556140335616,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.02 [0.97-1.07],0.496796987416473,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.94 [0.79-1.12],0.499908651374332,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.96 [0.85-1.08],0.501573929567473,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL6,Interleukin-6,Inverse variance weighted,6,1.03 [0.95-1.12],0.501615616587072,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.86 [0.56-1.33],0.50175222019863,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,0.96 [0.85-1.09],0.502789221581542,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP3,Stromelysin-1,Inverse variance weighted,4,0.93 [0.74-1.16],0.503132870980578,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD70,CD70 antigen,Inverse variance weighted,11,1.02 [0.96-1.09],0.504794376640966,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRTN3,Myeloblastin,Inverse variance weighted,20,1.02 [0.96-1.09],0.505661008995849,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.04 [0.93-1.16],0.507961720351064,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.03 [0.94-1.14],0.513125802016983,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.98 [0.92-1.05],0.513910463439446,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.05 [0.9-1.23],0.514666763855817,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1.02 [0.97-1.06],0.51712858001941,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.07 [0.87-1.31],0.517517799340655,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.02 [0.96-1.08],0.521206433590214,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.06 [0.89-1.25],0.521740457038458,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPON1,Spondin-1,Inverse variance weighted,4,0.94 [0.76-1.15],0.52300037998042,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.96 [0.85-1.09],0.524287511465991,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.91 [0.69-1.21],0.525116815405117,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.06 [0.89-1.25],0.525937568966608,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.96 [0.85-1.08],0.526099203971356,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.96 [0.83-1.1],0.526541562156824,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.95-1.1],0.53166588708213,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.01 [0.98-1.05],0.532944768345907,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.88 [0.59-1.31],0.534116006169567,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.98 [0.91-1.05],0.53652644796194,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.02 [0.96-1.07],0.537872154059487,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.99 [0.94-1.03],0.544606170580229,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.07 [0.86-1.32],0.545744333507771,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XCL1,Lymphotactin,Inverse variance weighted,15,0.96 [0.85-1.09],0.551834479519119,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPO,Erythropoietin,Inverse variance weighted,11,1.02 [0.95-1.09],0.552499818125429,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.97 [0.89-1.07],0.552852252574542,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPOCK1,Testican-1,Inverse variance weighted,26,0.98 [0.9-1.06],0.554163523240442,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.02 [0.94-1.11],0.555761518597854,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TTR,Transthyretin,Inverse variance weighted,11,1.02 [0.95-1.1],0.556671418967826,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.86 [0.53-1.41],0.559820478407617,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.95 [0.81-1.12],0.561015340826242,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.04 [0.92-1.18],0.561268083701648,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGAM,Integrin alpha-M,Inverse variance weighted,12,0.98 [0.9-1.06],0.562593780599724,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NECTIN2,Nectin-2,Inverse variance weighted,3,1.09 [0.82-1.43],0.565001253284853,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.09 [0.81-1.45],0.567208457370452,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.01 [0.97-1.05],0.567902821591904,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.12 [0.75-1.69],0.570335694954856,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD276,CD276 antigen,Inverse variance weighted,24,1.02 [0.96-1.09],0.572310559992338,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPT,Dermatopontin,Inverse variance weighted,4,1.06 [0.87-1.3],0.573681141097841,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.97 [0.88-1.07],0.574661402680245,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.93 [0.71-1.21],0.578285496935796,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.02 [0.94-1.11],0.579094595356081,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.06 [0.87-1.29],0.580093191846392,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPP1,Osteopontin,Inverse variance weighted,13,0.96 [0.85-1.1],0.581375982935466,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CALCA,Calcitonin,Inverse variance weighted,13,1.04 [0.9-1.21],0.584977463000202,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NRP2,Neuropilin-2,Inverse variance weighted,14,0.97 [0.88-1.07],0.59151644664846,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.08 [0.81-1.44],0.596635259023672,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.02 [0.94-1.1],0.59707500229434,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.98 [0.92-1.05],0.597714044164352,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.01 [0.96-1.07],0.602602670345723,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRH,Corticoliberin,Inverse variance weighted,55,1.01 [0.97-1.05],0.603067325956438,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,0.97 [0.88-1.07],0.603314687590615,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.94 [0.76-1.17],0.604427764694599,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.98-1.03],0.607519723856303,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,1.02 [0.94-1.11],0.607541965132506,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.05 [0.88-1.24],0.60789193279953,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.09 [0.77-1.55],0.610218526792001,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GSN,Gelsolin,Inverse variance weighted,7,1.03 [0.92-1.16],0.614548430229795,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.98-1.04],0.616164234242802,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PZP,Pregnancy zone protein,Inverse variance weighted,7,0.96 [0.82-1.12],0.617360213938566,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.94-1.11],0.620364627561858,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SDC4,Syndecan-4,Inverse variance weighted,35,0.99 [0.94-1.04],0.623316689322548,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,0.98 [0.9-1.07],0.625618594233724,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.98 [0.92-1.05],0.629121529068479,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL10,Interleukin-10,Inverse variance weighted,4,1.02 [0.94-1.1],0.629699961094972,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.02 [0.93-1.12],0.630113970254484,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,0.99 [0.95-1.03],0.630434303650756,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AGRN,Agrin,Inverse variance weighted,14,1.03 [0.91-1.17],0.630660461269967,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.9 [0.6-1.37],0.632086163330088,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.02 [0.93-1.13],0.637835852494633,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,AREG,Amphiregulin,Inverse variance weighted,5,1.04 [0.89-1.2],0.638908841317788,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MPO,Myeloperoxidase,Inverse variance weighted,17,1.01 [0.96-1.07],0.639412550204284,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.96 [0.82-1.13],0.640148127980588,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.94 [0.73-1.21],0.641983752438923,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.94 [0.73-1.22],0.643018660870115,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.96-1.03],0.644420615766752,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.96 [0.79-1.16],0.645109255086727,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.03 [0.91-1.16],0.648001763377838,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHGA,Chromogranin-A,Inverse variance weighted,5,0.96 [0.81-1.14],0.649690560200499,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.08 [0.77-1.52],0.650482041941563,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,1.01 [0.96-1.07],0.65186575377672,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.04 [0.88-1.22],0.6532039352179,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.01 [0.96-1.07],0.653652183462433,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.02 [0.93-1.12],0.654932011774788,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GAST,Gastrin,Inverse variance weighted,9,1.03 [0.92-1.15],0.655796382975389,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MATN2,Matrilin-2,Inverse variance weighted,28,1.01 [0.98-1.04],0.655921299238764,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.05 [0.83-1.33],0.657600197766221,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ALCAM,CD166 antigen,Inverse variance weighted,4,1.05 [0.85-1.3],0.659837411532623,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.99 [0.93-1.05],0.664688794339136,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.98 [0.88-1.08],0.665441709603372,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.02 [0.92-1.15],0.666662082564362,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.09 [0.74-1.59],0.668139785666039,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CNTN5,Contactin-5,Inverse variance weighted,22,1.01 [0.95-1.08],0.670722800159026,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SELENOP,Selenoprotein P,Inverse variance weighted,3,0.94 [0.72-1.23],0.672506620964466,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BSG,Basigin,Inverse variance weighted,6,0.97 [0.83-1.13],0.675849798619683,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.87-1.09],0.685940865621769,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.04 [0.87-1.23],0.688481326905112,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,0.98 [0.9-1.07],0.689706546169214,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.95 [0.72-1.24],0.689835118207519,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCG2,Secretogranin-2,Inverse variance weighted,2,0.96 [0.78-1.18],0.692445094046444,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.04 [0.85-1.28],0.692487922066291,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C9,Complement component C9,Inverse variance weighted,7,0.97 [0.85-1.12],0.705397257105109,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.98 [0.9-1.08],0.708223437480486,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OCLN,Occludin,Inverse variance weighted,2,1.08 [0.73-1.6],0.71403299580044,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.96 [0.76-1.2],0.71553113196107,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.02 [0.9-1.16],0.716343504713595,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,0.96 [0.76-1.21],0.718945933996444,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.98 [0.88-1.09],0.721354917764467,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.96 [0.75-1.22],0.722279571948174,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.99 [0.96-1.03],0.724377239159724,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.96 [0.75-1.22],0.726496006478232,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.99 [0.93-1.05],0.726951304719996,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.98 [0.87-1.1],0.73015185057575,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.02 [0.93-1.11],0.731160871141994,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.97 [0.79-1.18],0.734854677103807,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.01 [0.94-1.09],0.735429597949662,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.98 [0.89-1.09],0.743201488060374,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.02 [0.92-1.12],0.743930625852209,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.99 [0.91-1.07],0.747304875857368,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PRSS8,Prostasin,Inverse variance weighted,14,1.01 [0.94-1.1],0.747546473861277,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.98 [0.88-1.1],0.747732519939812,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.94 [0.65-1.36],0.753060008771014,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THBD,Thrombomodulin,Inverse variance weighted,11,0.99 [0.9-1.08],0.754839376799908,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.97 [0.82-1.16],0.757371608589342,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.03 [0.84-1.28],0.757890509734925,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.98 [0.88-1.09],0.758471099398748,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,0.98 [0.86-1.12],0.759325502245204,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PVR,Poliovirus receptor,Inverse variance weighted,3,0.96 [0.76-1.22],0.759544386191866,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.98 [0.86-1.12],0.760752838016006,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.99 [0.91-1.07],0.762009824617837,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.98 [0.84-1.13],0.763825417479255,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.98 [0.89-1.09],0.76442683960123,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,0.99 [0.93-1.06],0.765220057950411,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.99 [0.92-1.07],0.766507677870209,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.02 [0.9-1.15],0.767684529288616,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.04 [0.81-1.34],0.773815409409946,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,0.99 [0.94-1.05],0.77408874470542,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,38,1 [0.97-1.02],0.774210590989845,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.06 [0.73-1.53],0.776807286671996,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,4,0.97 [0.81-1.17],0.777246630008793,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,1.01 [0.91-1.13],0.781419744320678,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.99 [0.91-1.07],0.783121361451023,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.01 [0.97-1.04],0.785788262277644,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.03 [0.82-1.3],0.79470729466244,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1 [0.97-1.04],0.794823674413723,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.01 [0.92-1.11],0.796944907727446,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.99 [0.92-1.06],0.798691038227187,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCN5,CCN family member 5,Inverse variance weighted,12,1.01 [0.95-1.07],0.800863706172928,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.97 [0.8-1.19],0.800894552766809,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.03 [0.79-1.35],0.804373478793994,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.98 [0.86-1.13],0.809588880326828,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.02 [0.88-1.18],0.811320909509344,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.94-1.05],0.811942477730369,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.03 [0.8-1.33],0.812084146673125,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.03 [0.83-1.26],0.812404370044687,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1 [0.96-1.03],0.813751362913348,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,1.03 [0.81-1.31],0.813834951056761,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.06 [0.66-1.7],0.814951514860075,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.93 [0.48-1.77],0.816633934266996,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,1.01 [0.96-1.05],0.821519413122277,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.02 [0.84-1.25],0.822179218638596,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HJV,Hemojuvelin,Inverse variance weighted,2,0.96 [0.67-1.37],0.823072913933632,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BCAN,Brevican core protein,Inverse variance weighted,12,1.01 [0.91-1.13],0.824050337393732,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.03 [0.8-1.33],0.831120008971587,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PALM2,Paralemmin-2,Inverse variance weighted,9,0.99 [0.93-1.06],0.832847271383744,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,0.99 [0.93-1.06],0.833062558897399,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL22,Interleukin-22,Inverse variance weighted,4,0.98 [0.8-1.2],0.833173665225228,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.99 [0.93-1.06],0.833782645897708,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.96 [0.68-1.37],0.834868989266954,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.99 [0.87-1.12],0.835281084351788,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.99 [0.88-1.11],0.839227379535972,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.03 [0.79-1.33],0.84088914298539,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.01 [0.92-1.11],0.841355300752026,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.04 [0.73-1.48],0.845908843629004,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.96 [0.67-1.4],0.84973137154384,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.03 [0.78-1.35],0.854600625798222,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.97 [0.72-1.32],0.855316409021173,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.01 [0.91-1.12],0.861287623195275,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.01 [0.9-1.13],0.863009781714799,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1 [0.95-1.05],0.865445912625722,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.99 [0.83-1.16],0.865459650421469,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.02 [0.85-1.22],0.866721186419852,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.01 [0.93-1.09],0.867843565535319,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1 [0.96-1.05],0.878440424911982,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.01 [0.91-1.12],0.878641457643068,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.01 [0.88-1.17],0.879247212041839,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.99 [0.9-1.09],0.879714157527797,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SDC1,Syndecan-1,Inverse variance weighted,12,0.99 [0.91-1.08],0.882668415050986,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MYL3,Myosin light chain 3,Inverse variance weighted,13,1.01 [0.92-1.11],0.883191188369019,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MB,Myoglobin,Inverse variance weighted,9,0.99 [0.87-1.12],0.88401806289895,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1 [0.95-1.07],0.884085927254147,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.01 [0.88-1.16],0.889028379647986,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.99 [0.8-1.21],0.890754981997206,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.97 [0.63-1.48],0.891564886438367,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.99 [0.88-1.11],0.892305780676436,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.99 [0.91-1.08],0.897515486886844,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CD160,CD160 antigen,Inverse variance weighted,24,1 [0.93-1.06],0.898589549735707,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,THBS2,Thrombospondin-2,Inverse variance weighted,15,1 [0.94-1.07],0.90077826959028,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.01 [0.88-1.15],0.903848926182681,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.01 [0.83-1.24],0.905486749321122,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.96-1.05],0.90623607379359,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SNCG,Gamma-synuclein,Inverse variance weighted,47,1 [0.98-1.03],0.907124014521602,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.02 [0.77-1.34],0.909191382281702,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1 [0.94-1.08],0.910267956739284,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.01 [0.88-1.15],0.91031662104442,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1 [0.98-1.02],0.912771668159562,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LMNB2,Lamin-B2,Inverse variance weighted,8,0.99 [0.82-1.19],0.913796192401947,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAM3B,Protein FAM3B,Inverse variance weighted,26,1 [0.97-1.03],0.914366711556601,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.99 [0.89-1.11],0.91597502749845,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SPON2,Spondin-2,Inverse variance weighted,3,1.01 [0.81-1.27],0.91783257391305,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1 [0.95-1.05],0.92094869317781,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ANG,Angiogenin,Inverse variance weighted,8,0.99 [0.8-1.22],0.921748021821818,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.01 [0.82-1.24],0.923337566438552,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.99 [0.88-1.12],0.927646993641712,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,COLEC12,Collectin-12,Inverse variance weighted,3,1.01 [0.74-1.39],0.93357591901216,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1 [0.91-1.09],0.936868632746554,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,0.99 [0.83-1.19],0.93912033921541,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,0.98 [0.63-1.53],0.940241853247029,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,OSM,Oncostatin-M,Inverse variance weighted,6,1 [0.91-1.11],0.942561406713335,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LCN15,Lipocalin-15,Inverse variance weighted,22,1 [0.97-1.03],0.945876671505907,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FBLN2,Fibulin-2,Inverse variance weighted,6,1 [0.89-1.14],0.948133295422576,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TSPAN1,Tetraspanin-1,Inverse variance weighted,3,1.01 [0.78-1.3],0.952940792286382,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.99 [0.8-1.23],0.958948522050064,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,1 [0.88-1.14],0.963546115453647,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.99 [0.61-1.59],0.963651419677183,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1 [0.95-1.05],0.964138103496604,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KLK11,Kallikrein-11,Inverse variance weighted,13,1 [0.92-1.09],0.968069898804345,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1 [0.94-1.06],0.970323909022242,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.98-1.02],0.970418342184001,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1 [0.87-1.14],0.971077041574241,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1 [0.76-1.3],0.97493938157012,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1 [0.89-1.13],0.979963471044635,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1 [0.71-1.43],0.981160368582541,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1 [0.9-1.12],0.983363544473408,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1 [0.8-1.26],0.984879375914814,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1 [0.85-1.18],0.988088460043904,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,IL17C,Interleukin-17C,Inverse variance weighted,5,1 [0.83-1.21],0.990138356923348,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,ELN,Elastin,Inverse variance weighted,10,1 [0.87-1.14],0.990259168662046,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1 [0.9-1.11],0.992209986915833,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1 [0.86-1.16],0.992796744887089,trans
Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1 [0.96-1.04],0.995462635471761,trans
